US Patent 10751414 Methods of treating psoriasis using PD-1 binding antibodies
Patent 10751414 was granted and assigned to Celgene on August, 2020 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10751414 Methods of treating psoriasis using PD-1 binding antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
